Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Moodys
Mallinckrodt
AstraZeneca
Johnson and Johnson

Last Updated: March 20, 2023

Litigation for LIVALO


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


US Court Litigation for LIVALO

Glossary
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,465,477 See Plans and Pricing See Plans and Pricing 2014-07-24 2015-02-19 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
6,465,477 See Plans and Pricing See Plans and Pricing 2014-04-09 2015-12-07 35:271 Patent Infringement District Court, S.D. New York Defendant See Plans and Pricing
6,465,477 See Plans and Pricing See Plans and Pricing 2014-04-09 2015-12-08 35:271 Patent Infringement District Court, S.D. New York Defendant See Plans and Pricing
6,465,477 See Plans and Pricing See Plans and Pricing 2014-04-14 2016-09-19 35:271 Patent Infringement District Court, S.D. New York See Plans and Pricing
6,465,477 Kowa Company, Ltd. v. Orient Pharma Co., Ltd. See Plans and Pricing 2014-04-17 2017-01-10 35:271 Patent Infringement District Court, S.D. New York None See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or Try a Trial

Patent Trial and Appeal Board Cases for LIVALO

Glossary
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,856,336 Mylan Pharmaceuticals Inc. See Plans and Pricing 2015-04-18 04-18-2015 Nissan Chemical Industries, Ltd. Inter partes review See Plans and Pricing 10-20-2015 YOSHIHIRO FUJIKAWA See Plans and Pricing
5,856,336 Sawai USA, Inc. See Plans and Pricing 2015-07-31 07-31-2015 Nissan Chemical Industries Ltd. Inter partes review See Plans and Pricing 02-04-2016 YOSHIHIRO FUJIKAWA See Plans and Pricing
5,856,336 Sawai USA, Inc. See Plans and Pricing 2015-07-31 07-31-2015 Nissan Chemical Industries Ltd. Inter partes review See Plans and Pricing 02-04-2016 YOSHIHIRO FUJIKAWA See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or Try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKesson
AstraZeneca
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2023 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
 NCE-1 Patent Challenge Dates 2023 - 2024
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group